1. Home
  2. ELUT vs DARE Comparison

ELUT vs DARE Comparison

Compare ELUT & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.95

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$1.70

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
DARE
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3M
24.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ELUT
DARE
Price
$0.95
$1.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$7.00
$10.00
AVG Volume (30 Days)
275.6K
76.0K
Earning Date
03-05-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,746,000.00
N/A
Revenue This Year
N/A
$3,843.33
Revenue Next Year
N/A
$8,700.33
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.50
$1.61
52 Week High
$3.46
$9.19

Technical Indicators

Market Signals
Indicator
ELUT
DARE
Relative Strength Index (RSI) 56.14 37.75
Support Level $0.85 $1.68
Resistance Level $1.04 $1.77
Average True Range (ATR) 0.10 0.08
MACD -0.02 -0.01
Stochastic Oscillator 35.96 15.63

Price Performance

Historical Comparison
ELUT
DARE

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: